Perigon Wealth Management LLC Makes New Investment in Corteva, Inc. $CTVA

Perigon Wealth Management LLC purchased a new stake in Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to its most recent filing with the SEC. The fund purchased 16,010 shares of the company’s stock, valued at approximately $1,356,000.

A number of other large investors also recently made changes to their positions in CTVA. Brighton Jones LLC grew its position in shares of Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after purchasing an additional 11,760 shares during the period. Woodline Partners LP lifted its position in Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after buying an additional 16,644 shares during the period. EverSource Wealth Advisors LLC lifted its position in Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after buying an additional 980 shares during the period. Cresset Asset Management LLC boosted its stake in Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after buying an additional 181 shares during the last quarter. Finally, Jump Financial LLC acquired a new stake in Corteva in the 2nd quarter worth about $1,464,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Corteva stock opened at $77.97 on Wednesday. The company has a market cap of $52.02 billion, a price-to-earnings ratio of 51.64, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The stock’s 50-day moving average is $81.84 and its 200-day moving average is $80.12.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is currently 47.68%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Royal Bank Of Canada upped their price objective on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday, July 21st. CICC Research raised their target price on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. BNP Paribas Exane boosted their target price on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. BMO Capital Markets upped their price target on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, August 3rd. Finally, JPMorgan Chase & Co. increased their price target on shares of Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.